Project Details
Description
A Phase 2, Multicenter Study to Assess the Safety and Efficacy of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Treatment of Patients with Metastatic Melanoma
Status | Active |
---|---|
Effective start/end date | 5/1/17 → 12/31/24 |
Funding
- IOVANCE BIOTHERAPEUTICS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.